UBS Group’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $65.9M | Buy |
834,191
+291,079
| +54% | +$24.7M | 0.01% | 1482 |
|
|
2026
Q1 | $46.8M | Buy |
543,112
+203,840
| +60% | +$18.3M | 0.01% | 1709 |
|
|
2025
Q4 | $29.6M | Sell |
339,272
-356,086
| -51% | -$27M | ﹤0.01% | 2187 |
|
|
2025
Q3 | $39.8M | Buy |
695,358
+207,721
| +43% | +$12M | 0.01% | 1857 |
|
|
2025
Q2 | $28.8M | Sell |
487,637
-520,561
| -52% | -$33.6M | 0.01% | 2013 |
|
|
2025
Q1 | $73.8M | Buy |
1,008,198
+665,953
| +195% | +$55M | 0.01% | 1133 |
|
|
2024
Q4 | $28.3M | Buy |
342,245
+155,467
| +83% | +$12.3M | 0.01% | 1966 |
|
|
2024
Q3 | $13.4M | Buy |
186,778
+1,804
| +1% | +$127K | ﹤0.01% | 2131 |
|
|
2024
Q2 | $12.7M | Buy |
184,974
+8,439
| +5% | +$504K | ﹤0.01% | 2036 |
|
|
2024
Q1 | $9.47M | Buy |
176,535
+7,363
| +4% | +$396K | ﹤0.01% | 2320 |
|
|
2023
Q4 | $9.02M | Sell |
169,172
-49,398
| -23% | -$2.41M | ﹤0.01% | 2188 |
|
|
2023
Q3 | $10.9M | Buy |
218,570
+106,269
| +95% | +$5.94M | ﹤0.01% | 1923 |
|
|
2023
Q2 | $6.69M | Buy |
112,301
+29,832
| +36% | +$1.7M | ﹤0.01% | 2304 |
|
|
2023
Q1 | $4.67M | Sell |
82,469
-30,587
| -27% | -$1.96M | ﹤0.01% | 2574 |
|
|
2022
Q4 | $8.4M | Buy |
113,056
+42,559
| +60% | +$2.9M | ﹤0.01% | 2051 |
|
|
2022
Q3 | $4.2M | Sell |
70,497
-114
| -0.2% | -$6.87K | ﹤0.01% | 2514 |
|
|
2022
Q2 | $3.96M | Sell |
70,611
-21,582
| -23% | -$1.42M | ﹤0.01% | 2566 |
|
|
2022
Q1 | $6.8M | Sell |
92,193
-46,985
| -34% | -$3.27M | ﹤0.01% | 2255 |
|
|
2021
Q4 | $10M | Buy |
139,178
+55,256
| +66% | +$4.01M | ﹤0.01% | 2134 |
|
|
2021
Q3 | $6.43M | Sell |
83,922
-5,435
| -6% | -$436K | ﹤0.01% | 2424 |
|
|
2021
Q2 | $6.93M | Buy |
89,357
+19,716
| +28% | +$1.4M | ﹤0.01% | 2358 |
|
|
2021
Q1 | $4.29M | Sell |
69,641
-3,258
| -4% | -$206K | ﹤0.01% | 2775 |
|
|
2020
Q4 | $4.75M | Sell |
72,899
-25,381
| -26% | -$1.46M | ﹤0.01% | 2493 |
|
|
2020
Q3 | $4.87M | Buy |
98,280
+61,723
| +169% | +$3.18M | ﹤0.01% | 2228 |
|
|
2020
Q2 | $1.74M | Sell |
36,557
-15,937
| -30% | -$769K | ﹤0.01% | 2998 |
|
|
2020
Q1 | $2.23M | Sell |
52,494
-116,216
| -69% | -$5.74M | ﹤0.01% | 2664 |
|
|
2019
Q4 | $9.93M | Buy |
168,710
+46,190
| +38% | +$2.51M | ﹤0.01% | 1958 |
|
|
2019
Q3 | $6.26M | Buy |
122,520
+48,851
| +66% | +$2.33M | ﹤0.01% | 2171 |
|
|
2019
Q2 | $3.12M | Sell |
73,669
-71,198
| -49% | -$3.09M | ﹤0.01% | 2741 |
|
|
2019
Q1 | $7.16M | Sell |
144,867
-134,861
| -48% | -$6.1M | ﹤0.01% | 1928 |
|
|
2018
Q4 | $12.1M | Buy |
279,728
+26,838
| +11% | +$1.34M | 0.01% | 1426 |
|
|
2018
Q3 | $14.4M | Buy |
252,890
+145,671
| +136% | +$7.67M | 0.01% | 1468 |
|
|
2018
Q2 | $5.41M | Buy |
107,219
+65,168
| +155% | +$3.4M | ﹤0.01% | 2275 |
|
|
2018
Q1 | $2.1M | Buy |
42,051
+5,030
| +14% | +$236K | ﹤0.01% | 3096 |
|
|
2017
Q4 | $1.52M | Sell |
37,021
-15,621
| -30% | -$547K | ﹤0.01% | 3424 |
|
|
2017
Q3 | $1.56M | Sell |
52,642
-20,523
| -28% | -$627K | ﹤0.01% | 3337 |
|
|
2017
Q2 | $2.42M | Sell |
73,165
-17,116
| -19% | -$538K | ﹤0.01% | 2834 |
|
|
2017
Q1 | $2.67M | Sell |
90,281
-22,887
| -20% | -$625K | ﹤0.01% | 2663 |
|
|
2016
Q4 | $2.81M | Buy |
113,168
+64,469
| +132% | +$1.47M | ﹤0.01% | 2608 |
|
|
2016
Q3 | $1.1M | Buy |
48,699
+13,189
| +37% | +$310K | ﹤0.01% | 3347 |
|
|
2016
Q2 | $847K | Sell |
35,510
-2,629
| -7% | -$63.1K | ﹤0.01% | 3520 |
|
|
2016
Q1 | $905K | Sell |
38,139
-6,586
| -15% | -$161K | ﹤0.01% | 3341 |
|
|
2015
Q4 | $1.24M | Buy |
44,725
+17,374
| +64% | +$436K | ﹤0.01% | 3234 |
|
|
2015
Q3 | $565K | Buy |
27,351
+6,174
| +29% | +$156K | ﹤0.01% | 3798 |
|
|
2015
Q2 | $544K | Buy |
21,177
+1,000
| +5% | +$25.3K | ﹤0.01% | 4047 |
|
|
2015
Q1 | $510K | Sell |
20,177
-9,598
| -32% | -$234K | ﹤0.01% | 4125 |
|
|
2014
Q4 | $708K | Buy |
+29,775
| New | +$659K | ﹤0.01% | 3873 |
|
Other funds holding GMED
JT
SC
UBS Group's GMED Position: Q2 2026 in Review
UBS Group increased its Globus Medical (GMED) stake by 54% in Q2 2026, buying an estimated $24.7M and bringing the position to 834,191 shares worth $65.9M. The position accounts for 0.01% of the portfolio, ranked #1482.
UBS Group first reported a position in GMED in Q4 2014 and has held it in 47 quarters since. The position peaked at $73.8M in Q1 2025. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- UBS Group held 834,191 shares of Globus Medical worth $65.9M as of Q2 2026.
- UBS Group bought 291,079 Globus Medical shares in Q2 2026, an estimated $24.7M.
- Globus Medical made up 0.01% of UBS Group's portfolio in Q2 2026, its #1482 holding.
- UBS Group first reported a position in Globus Medical in Q4 2014 and has held it in 47 quarters since.
- UBS Group's Globus Medical position peaked at $73.8M in Q1 2025.
- 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.